Clinical Trials for Rectal Cancer

5 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
OtherVICCGI0721
01/09/2007
Vanderbilt Hereditary Colorectal Cancer Registry
Supportive CareVICCREACH1341
09/05/2013
Using a Tailored Navigation Intervention to Prepare Patients and Their Support Person for the Journey at Time of Cancer Diagnosis and at Transition into Survivorship
TreatmentVICCPHI1394
04/17/2014
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients with Epithelial Cancer
TreatmentECOGGIS0820
09/03/2013
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)
TreatmentVICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers

You do not have JavaScript enabled. This site works better with JavaScript turned on.